Perception of Cure Among Patients With Metastatic Cancer
NCT04820894 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-05-23
Summary
This study collects information about perception of cure among patients with cancer that has spread to other places in the body (metastatic). This study aims to determine patients' perception (knowledge) before starting immunotherapy and if differences exist in understanding of treatment to stimulate or restore the ability of the body's immune (defense) system to fight infection and disease (immunotherapy) based on social and economic factors or on race/ethnicity.
Conditions
- Hematopoietic and Lymphoid Cell Neoplasm
- Metastatic Malignant Solid Neoplasm
Interventions
- OTHER
-
Electronic Medical Record
Medical records are reviewed
- OTHER
-
Survey Administration
Complete surveys
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
City of Hope Medical Center
lead OTHER
Principal Investigators
-
Sumanta K Pal · City of Hope Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-30
- Primary Completion
- 2022-01-05
- Completion
- 2022-01-05
More Related Trials
-
Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect
NCT03825510 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Cryoablation Combined With Radiation Therapy for the Palliation of Painful Bone Metastases
NCT01461252 ·Status: WITHDRAWN ·Phase: PHASE1
-
Feasibility of Supportive Care Needs in Patients With Advanced Solid Cancer in a Therapeutic Trial
NCT04896099 ·Status: COMPLETED
-
Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer
NCT03035890 ·Status: COMPLETED ·Phase: NA
-
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
NCT05703269 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer
NCT00048997 ·Status: COMPLETED ·Phase: PHASE3
-
Radiotherapy or Observation of Liver Metastases in Small Cell Lung Cancer
NCT05150145 ·Status: RECRUITING ·Phase: NA
-
Effectiveness of Stereotactic RadioTherapy in Solid Primary Inoperable and Oligometastatic Cancer
NCT03461822 ·Status: UNKNOWN
-
Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer
NCT00955695 ·Status: UNKNOWN ·Phase: PHASE3
-
Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet
NCT05351294 ·Status: SUSPENDED ·Phase: PHASE3
-
Investigation of the Timely-coordinated Therapy of Patients With Metastatic Cancer by Radiotherapy Together With Immune Checkpoint Inhibition
NCT03453892 ·Status: COMPLETED
-
Prospective Evaluation of Stereotactic Body Radiotherapy for Metastatic Prostate Cancer
NCT02206724 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer
NCT06431685 ·Status: RECRUITING ·Phase: PHASE1
-
A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC
NCT02463994 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Stereotactic Radiosurgery Dose Escalation for Brain Metastases
NCT02390518 ·Status: RECRUITING ·Phase: PHASE1
-
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
NCT06686771 ·Status: RECRUITING ·Phase: PHASE3
-
Definitive Therapy for Oligometastatic Solid Malignancies
NCT01898962 ·Status: UNKNOWN ·Phase: PHASE2
-
Stereotactic Radiosurgery in Treating Patients With Liver Metastases, Lung Metastases, or Other Advanced Solid Tumors
NCT00006456 ·Status: COMPLETED ·Phase: PHASE2
-
Analysis of Percutaneous Ablations for Cancer Treatment
NCT01563679 ·Status: COMPLETED
-
Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury
NCT00631839 ·Status: UNKNOWN
-
Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma
NCT04339218 ·Status: RECRUITING ·Phase: PHASE3
-
Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer
NCT05430009 ·Status: RECRUITING ·Phase: PHASE1
-
Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer
NCT05850663 ·Status: WITHDRAWN ·Phase: NA
-
Prophylactic Cranial Irradiation in Patients With Lung Adenocarcinoma With High Risk of Brain Metastasis
NCT01603849 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Spinal Metastatic Tumour for Aggressive Spinal Sugery by Dual Energy CT
NCT03631095 ·Status: COMPLETED